Lawrence J. Singerman

8.6k total citations · 1 hit paper
58 papers, 2.7k citations indexed

About

Lawrence J. Singerman is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Lawrence J. Singerman has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Ophthalmology, 27 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Lawrence J. Singerman's work include Retinal Diseases and Treatments (41 papers), Retinal and Optic Conditions (19 papers) and Retinal Imaging and Analysis (19 papers). Lawrence J. Singerman is often cited by papers focused on Retinal Diseases and Treatments (41 papers), Retinal and Optic Conditions (19 papers) and Retinal Imaging and Analysis (19 papers). Lawrence J. Singerman collaborates with scholars based in United States, Switzerland and United Kingdom. Lawrence J. Singerman's co-authors include Ingrid U. Scott, Clement K. Chan, Mark S. Rzeszotarski, Liang Yan, Marian R. Fisher, Michael S. Ip, Paul VanVeldhuisen, Michael J. Tolentino, Víctor H. González and Barbara A. Blodi and has published in prestigious journals such as Diabetes Care, Ophthalmology and IEEE Transactions on Medical Imaging.

In The Last Decade

Lawrence J. Singerman

55 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion

2009 535 citations Ingrid U. Scott, Lawrence J. Singerman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence J. Singerman United States	22	2.4k	1.6k	523	168	140	58	2.7k
Paolo S. Silva United States	30	3.1k 1.3×	2.7k 1.7×	371 0.7×	161 1.0×	61 0.4×	91	3.6k
Felix Graßmann Germany	25	1.1k 0.4×	739 0.5×	756 1.4×	83 0.5×	83 0.6×	68	1.9k
Lihteh Wu Costa Rica	31	3.3k 1.4×	2.4k 1.5×	402 0.8×	101 0.6×	28 0.2×	136	3.6k
Andrea Sodi Italy	26	1.2k 0.5×	591 0.4×	758 1.4×	149 0.9×	27 0.2×	137	1.9k
Joo Young Shin South Korea	24	826 0.3×	691 0.4×	253 0.5×	123 0.7×	57 0.4×	61	1.5k
Michael Ulbig Germany	33	3.5k 1.5×	3.0k 1.8×	660 1.3×	155 0.9×	23 0.2×	121	4.0k
Rosa Dolz‐Marco Spain	28	2.8k 1.2×	1.8k 1.1×	547 1.0×	156 0.9×	18 0.1×	155	3.1k
Maurízio Battaglia Parodi Italy	35	4.8k 2.0×	2.7k 1.7×	1.7k 3.2×	255 1.5×	25 0.2×	375	5.4k
Conceição Lobo Portugal	23	1.6k 0.7×	1.2k 0.8×	271 0.5×	164 1.0×	56 0.4×	69	1.9k
Rosangela Lattanzio Italy	24	1.5k 0.6×	1.2k 0.7×	256 0.5×	108 0.6×	14 0.1×	100	1.9k

Countries citing papers authored by Lawrence J. Singerman

Since Specialization

Citations

This map shows the geographic impact of Lawrence J. Singerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence J. Singerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence J. Singerman more than expected).

Fields of papers citing papers by Lawrence J. Singerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence J. Singerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence J. Singerman. The network helps show where Lawrence J. Singerman may publish in the future.

Co-authorship network of co-authors of Lawrence J. Singerman

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence J. Singerman. A scholar is included among the top collaborators of Lawrence J. Singerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence J. Singerman. Lawrence J. Singerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coney, Joseph, Thomas D. Hull, Michael Novák, et al.. (2025). Incidence of Recurrent Choroidal Neovascularization Following Treatment with Pegcetacoplan for Geographic Atrophy in Exudative Age-Related Macular Degeneration Patients with Inactive Choroidal Neovascularization. 6(1). 1–7.

Wykoff, Charles C., Frank G. Holz, Allen Chiang, et al.. (2025). Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE. American Journal of Ophthalmology. 276. 350–364. 1 indexed citations

Coney, Joseph, Thomas D. Hull, David Miller, et al.. (2023). One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents. Clinical ophthalmology. Volume 17. 3601–3611. 1 indexed citations

Chandra, Rohit, David Miller, Lawrence J. Singerman, et al.. (2019). Surgical Outcomes and Patient Satisfaction in Vitrectomy for Vitreous Floaters. Investigative Ophthalmology & Visual Science. 60(9). 5783–5783. 1 indexed citations

Chew, Emily Y., Traci E. Clemons, Glenn J. Jaffe, et al.. (2018). Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2. Ophthalmology. 126(4). 540–549. 110 indexed citations

Dugel, Pravin U., Glenn J. Jaffe, Peter Sallstig, et al.. (2017). Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial. Ophthalmology. 124(9). 1296–1304. 179 indexed citations

Zegarra, Hernando, Z. N. Zakov, Michael Novák, et al.. (2016). The use of anti-vascular endothelial growth factor therapies in the macular telangiectasia associated with choroidal neovascularization.. Investigative Ophthalmology & Visual Science. 57(12). 2145–2145. 1 indexed citations

Singerman, Lawrence J., Andreas Weichselberger, & Peter Sallstig. (2015). OSPREY trial: randomized, active-controlled, phase II study to evaluate safety and efficacy of RTH258, a humanized single-chain anti-VEGF antibody fragment, in patients with neovascular AMD. Investigative Ophthalmology & Visual Science. 56(7). 4801–4801. 7 indexed citations

Chew, Emily Y., Traci E. Clemons, Tünde Pető, et al.. (2014). Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial. American Journal of Ophthalmology. 159(4). 659–666.e1. 61 indexed citations

10.

Diana, V., Emily W. Gower, Sandra D. Cassard, et al.. (2012). Detection of New-Onset Choroidal Neovascularization Using Optical Coherence Tomography. Ophthalmology. 119(4). 771–778. 64 indexed citations

11.

Singerman, Lawrence J.. (2009). COMBINATION THERAPY USING THE SMALL INTERFERING RNA BEVASIRANIB. Retina. 29(6). S49–S50. 47 indexed citations

12.

Singerman, Lawrence J., Harvey Masonson, M. Patel, et al.. (2008). Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. British Journal of Ophthalmology. 92(12). 1606–1611. 107 indexed citations

13.

Scott, Ingrid U., Allison R. Edwards, Neil M. Bressler, et al.. (2007). A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema. Ophthalmology. 114(10). 1860–1867.e7. 344 indexed citations

14.

Miller, David & Lawrence J. Singerman. (2006). Vision Loss in Younger Patients: A Review of Choroidal Neovascularization. Optometry and Vision Science. 83(5). 316–325. 33 indexed citations

15.

Singerman, Lawrence J., et al.. (2004). Verteporfin with Altered (Delayed) Light In Occult (VALIO) – 12–Month Results of a Phase II Controlled Clinical Trial. Investigative Ophthalmology & Visual Science. 45(13). 2274–2274. 3 indexed citations

16.

Mittra, Robert A. & Lawrence J. Singerman. (2002). Recent Advances in the Management of Age-Related Macular Degeneration. Optometry and Vision Science. 79(4). 218–224. 18 indexed citations

17.

Maberley, David, Lawrence A. Yannuzzi, Kurt A. Gitter, et al.. (1999). Radiation exposure. Ophthalmology. 106(12). 2248–2253. 12 indexed citations

18.

Yan, Liang, et al.. (1994). The detection and quantification of retinopathy using digital angiograms. IEEE Transactions on Medical Imaging. 13(4). 619–626. 225 indexed citations

19.

Singerman, Lawrence J., et al.. (1989). Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 227(6). 501–507. 28 indexed citations

20.

Singerman, Lawrence J., et al.. (1988). Krypton laser for proliferative diabetic retinopathy: The Krypton Argon Regression of Neovascularization Study. Journal of Diabetic Complications. 2(4). 189–196. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact